Consorcio De Investigación E Innovación Abierta S A P I De C V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consorcio De Investigación E Innovación Abierta S A P I De C VfiledCriticalConsorcio De Investigación E Innovación Abierta S A P I De C V
Priority to MX2016002865ApriorityCriticalpatent/MX2016002865A/en
Publication of MX2016002865ApublicationCriticalpatent/MX2016002865A/en
The present disclosure is related with the nutrition, food technology and medicine technical field providing a nutraceutical for controlling the metabolic syndrome with the aim of promoting better health and a vitality feeling, improving the life quality of people. Therefore, the object of the present invention is to provide a nutraceutical for controlling the metabolic syndrome, especially in obesity patients, to reduce in a short time, at least three clinical parameters that the WHO mentions as necessary to be able to diagnose the metabolic syndrome; and achieving high solubility properties.
MX2016002865A2016-03-042016-03-04Nutraceutical for controlling the metabolic syndrome.
MX2016002865A
(en)
Compositions and formulations for prevention and treatment of diabetes and obesity, and methods of production and use thereof in glucose and caloric control.
Nutraceutical solution based on agave inulin and method for using the same for relieving the symptoms related to hepatic encephalopathy in patients with hepatic cirrhosis.